Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:55:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces the older Revision: v3.4.0 on the page, indicating a version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T10:57:34.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    UI updates add a 'Show glossary' option and update QC-related fields (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision updated to v3.4.0 (from v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T07:26:13.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A minor revision banner update was made: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:37:25.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The study locations were expanded to include many new sites across the US, Canada, and other regions, and the HHS Vulnerability Disclosure link was removed.
    Difference
    2%
    Check dated 2025-12-23T21:09:24.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    A new sentence is added to Publications indicating publications are provided voluntarily by the submitter, and the descriptor changes from 'about the study results' to 'about the results of the study'; the revision tag updates to v3.3.2 (replacing v3.2.0).
    Difference
    0.3%
    Check dated 2025-11-25T10:27:05.000Z thumbnail image

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.